AT305288B - Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone - Google Patents

Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Info

Publication number
AT305288B
AT305288B AT194271A AT194271A AT305288B AT 305288 B AT305288 B AT 305288B AT 194271 A AT194271 A AT 194271A AT 194271 A AT194271 A AT 194271A AT 305288 B AT305288 B AT 305288B
Authority
AT
Austria
Prior art keywords
pyrimidones
preparation
new
substituted tetrahydro
tetrahydro
Prior art date
Application number
AT194271A
Other languages
German (de)
English (en)
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Application granted granted Critical
Publication of AT305288B publication Critical patent/AT305288B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
AT194271A 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone AT305288B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1698270A 1970-03-05 1970-03-05

Publications (1)

Publication Number Publication Date
AT305288B true AT305288B (de) 1973-02-26

Family

ID=21780073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT194271A AT305288B (de) 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Country Status (14)

Country Link
US (1) US3681349A (enExample)
AT (1) AT305288B (enExample)
BE (1) BE763745A (enExample)
CH (1) CH555343A (enExample)
DE (1) DE2110445C3 (enExample)
DK (1) DK127427B (enExample)
ES (1) ES388780A1 (enExample)
FR (1) FR2085673B1 (enExample)
GB (1) GB1294626A (enExample)
IL (1) IL36189A0 (enExample)
NL (1) NL7102519A (enExample)
NO (1) NO130728C (enExample)
SE (1) SE376420B (enExample)
ZA (1) ZA71928B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39003A (en) * 1971-03-25 1975-02-10 Morton Norwich Products Inc 1-(substituted benzyl)tetrahydro-2-(1h)-pyrimidones and their preparation
US3957785A (en) * 1971-12-02 1976-05-18 Societa' Farmaceutici Italia S.P.A. Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
US3956325A (en) * 1974-01-21 1976-05-11 Smithkline Corporation 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone
US4003900A (en) * 1976-03-11 1977-01-18 Morton-Norwich Products, Inc. 1-Benzyl-5-chloro-2-(1H)-pyrimidone
US4002627A (en) * 1976-03-26 1977-01-11 Morton-Norwich Products, Inc. 1-Benzyl-3-methyl-3,4,5,6-tetrahydro-2(1H) pyrimidone
US4052399A (en) * 1976-09-13 1977-10-04 Morton-Norwich Products, Inc. 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) * 1976-10-29 1977-10-04 Morton-Norwich Products, Inc. Hypertensive 1-substituted 2(1h)-pyrimidones
EP2125750B1 (en) * 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8329897B2 (en) * 2007-07-26 2012-12-11 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の環状尿素阻害剤
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
EP2254872A2 (en) * 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EP2274287B1 (en) * 2008-03-18 2016-03-09 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
JP5538365B2 (ja) * 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
EP2291373B1 (en) * 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2722427A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001058A1 (es) * 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤
WO2010010150A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
RU2539979C2 (ru) * 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US20100331320A1 (en) * 2009-04-30 2010-12-30 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5750449B2 (ja) 2009-11-05 2015-07-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規キラルリンリガンド
TWI531571B (zh) * 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜芳基羰基衍生物
EP2576570A1 (en) 2010-05-26 2013-04-10 Boehringer Ingelheim International GmbH 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための１１−β−ＨＳＤ１のインヒビターとしてのアザスピロヘキサノン
BR112013010021A2 (pt) 2010-11-02 2019-09-24 Boehringer Ingelheim Int combinações farmacêuticas para o tratamento de distúrbios metabólicos.
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE562987A (enExample) * 1956-12-05
DE1121617B (de) * 1959-05-26 1962-01-11 Huels Chemische Werke Ag Verfahren zur Herstellung von Tetrahydropyrimidin-2-onderivaten
DE1545601A1 (de) * 1965-07-22 1969-08-07 Basf Ag Verfahren zur Herstellung von Hexahydro-pyrimidinderivaten
DE1670368A1 (de) * 1966-07-16 1970-11-05 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung aralkylsubstituierter Lactame und Cyclischer Harnstoffe
DE1670241A1 (de) * 1967-07-01 1971-01-28 Basf Ag Verfahren zur Herstellung von 2-Oxohexahydropyrimidinen

Also Published As

Publication number Publication date
FR2085673B1 (enExample) 1974-09-06
IL36189A0 (en) 1971-04-28
DK127427B (da) 1973-11-05
NO130728C (enExample) 1975-01-29
NL7102519A (enExample) 1971-09-07
ES388780A1 (es) 1975-03-01
ZA71928B (en) 1972-09-27
DE2110445C3 (de) 1975-05-28
US3681349A (en) 1972-08-01
SE376420B (enExample) 1975-05-26
CH555343A (de) 1974-10-31
DE2110445A1 (de) 1971-11-04
BE763745A (fr) 1971-09-03
NO130728B (enExample) 1974-10-21
GB1294626A (en) 1972-11-01
DE2110445B2 (de) 1974-10-10
FR2085673A1 (enExample) 1971-12-31

Similar Documents

Publication Publication Date Title
CH555343A (de) Verfahren zur herstellung neuer 1-benzyl-tetrahydro-2(1h)pyrimidonen.
CH531000A (de) Verfahren zur Herstellung neuer Benzocycloheptathiophene
CH530415A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT317229B (de) Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen
AT311351B (de) Verfahren zur Herstellung neuer 1-Isopropyl-4-phenyl-2(1H)-chinazolinone
AT306731B (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone
DK130115B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner.
CH507959A (de) Verfahren zur Herstellung neuer Pyrimidin-Derivate
CH515911A (de) Verfahren zur Herstellung von 3,4-Dihydro-4-phenyl-2(1H)-chinazolinonen
CH555816A (de) Verfahren zur herstellung von acetamid-s-oxid-verbindungen.
AT306046B (de) Verfahren zur Herstellung von neuen semicyclischen Amidinen
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH533120A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT313901B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinverbindungen
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT301562B (de) Verfahren zur Herstellung von neuen 2,6-Dimorpholino-8-alkanolamino-pyrimido[5,4-d]pyrimidinen
CH514596A (de) Verfahren zur Herstellung von 4-Phenylchinazolin-2(1H)-thionen
CH557371A (de) Verfahren zur herstellung von substituierten 5-hydroxyoenanthsaeurelactonen.
AT308714B (de) Verfahren zur Herstellung von Hydroxypivalaldehyd
AT308106B (de) Verfahren zur Herstellung neuer 2-(4-Oxo-4H-1-benzopyran-7-yl)-oxy-isobuttersäure-Derivate
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.
AT316148B (de) Verfahren zur Herstellung von löslichen Kondensationsprodukten
AT303744B (de) Verfahren zur Herstellung von 1-[(2'-Alkyl-4'-amino-pyrimidyl-5')-methyl]-pyridinium-Derivaten
CH514603A (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone